This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


Progress in genetic testing in congenital heart disease

Progresses in genetic testing in congenital heart disease
The coverage of variants yielded by testing technologies is indicated. Structural variants may entail duplications, deletions, and unbalanced insertions, while positional changes may involve balanced translocations, insertions, or inversions. Credit: Science China Press

Congenital heart disease (CHD) includes a variety of structural malformations affecting the heart and blood vessels. With growing understanding of the molecular processes involved in heart development, genetic variants have been proven to play a crucial role in the development of CHD.

Researchers have identified a range of genetic variations associated with both syndromic and non-syndromic CHD, including single nucleotide variations, structural variations, and chromosomal abnormalities. The research is published in the journal Medicine Plus.

As technologies improve, the application of genetic testing in CHD patients yields valuable insights in the aspects of both clinical and research settings.

With the advancement of cohort studies, genetic data can be effectively collected from genetic testing and categorized by pathogenicity, enhancing comprehension of CHD genetics. Many tools have been created to interpret variants identified in both coding and non-coding regions, providing valuable information for in CHD management. The integration of genetic testing could benefit CHD management in several aspects, including diagnosis, prognosis prediction, and recurrence risk estimation.

In conclusion, with ongoing advancement in understanding of genetic testing and CHD, can effectively incorporate genetic testing into the broader framework of CHD care, leading to better patient outcomes.

More information: Han Gao et al, Progresses in genetic testing in congenital heart disease, Medicine Plus (2024). DOI: 10.1016/j.medp.2024.100028

Citation: Progress in genetic testing in congenital heart disease (2024, May 16) retrieved 21 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Black people half as likely to be evaluated for genetic testing as white people, finds study


Feedback to editors